Literature DB >> 567761

Intravenous phenytoin: clinical and pharmacokinetic aspects.

R E Cranford, I E Leppik, B Patrick, C B Anderson, B Kostick.   

Abstract

Phenytoin was administered intravenously in large doses (mean = 16.6 mg per kilogram) for prevention and treatment of seizures on 159 occasions to 139 patients aged 17 to 94 years (mean = 52 years) and weighing 37 to 113 kg (mean = 65 kg). Hypotension was more frequent among older patients. No deaths were attributable to phenytoin. Volumes of distribution were relatively constant (mean = 0.78 +/- 0.11 liters per kilogram), but half-lives varied considerably and were prolonged (mean = 51 +/- 32 hours) because of the large doses administered. A dose of 18 mg per kilogram was effective in maintaining phenytoin serum levels above 10 microgram per milliliter for 24 hours.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567761     DOI: 10.1212/wnl.28.9.874

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Dr watson responds.

Authors:  C Watson
Journal:  West J Med       Date:  1992-05

2.  Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.

Authors:  Christa B Swisher; Meghana Doreswamy; Krista J Gingrich; James J Vredenburgh; Brad J Kolls
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

Review 3.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Tonic clonic status epilepticus.

Authors:  S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

Review 6.  How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?

Authors:  C A Gentry; K A Rodvold
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

7.  Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

Authors:  Bernhards R Ogutu; Charles R J C Newton; Simon N Muchohi; Godfrey O Otieno; Geoffrey Edwards; William M Watkins; Gilbert O Kokwaro
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Treatment of status epilepticus in children.

Authors:  P R Camfield
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262

10.  Treatment of status epilepticus in adults.

Authors:  J Bruni
Journal:  Can Med Assoc J       Date:  1983-03-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.